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To the editor
Transcranial direct current stimulation (tDCS) has attracted considerable interest in recent years, especially as a potential intervention in stroke rehabilitation and the treatment of depression. Common safety guidelines exist to ensure the safety of the procedure [1] . However, mild adverse effects (AEs) are common and more severe AEs are occasionally encountered. Here, we report two cases of skin lesions following tDCS.
Two females (aged 18 and 19 years) participated in experimental tDCS studies focusing on cognition. A NeuroConn (Ilmenau, Germany) stimulator was used. Stimulation was delivered using carbon-rubber electrodes (5 Â 7 cm 2 ) fully enclosed inside conventional reusable saline-soaked sponges. No metal parts were exposed. A 20-ml pod of saline was used for the two electrodes. The electrical current was 1.5 mA for 15 min, with 16 seconds of fade-in and fadeout. The same stimulator was used for all the stimulations, and the output of the stimulator was verified after the stimulations. The subjects rested their hands on a normal wooden office desk. The anode was placed over the left dorsolateral prefrontal cortex (F3 in the 10e20 international EEG electrode placement system) and the cathode on the left wrist. A sports bandage was used to hold the electrodes in place, and impedance at the beginning was <10k ohms. The sports bandage was routinely replaced after 5e6 sessions. Neither of the participants reported burning sensations or discomfort during the stimulation. The studies from which these cases were derived were approved by the ethics committee of University College London and the University of Kent. Participants gave written informed consent. The experimenter in all these sessions was the senior investigator, who had ample experience in tDCS.
Participant #1 e Only redness of the skin was observable poststimulation. After two days, the participant reported an itchy, lumpy lesion (diameter ca. 8mm) on the dorsal side of her wrist, in the electrode placement area. From day 4, the participant used zinc oxide cream to promote healing. See Fig. 1a and b for images taken on days 2 and 6. With the participant's permission, she was contacted on day 18 and reported that the lesion was healing well. She was asked to send a photo, but she did not maintain communication after this point.
Participant #2 e Similarly to Participant #1, no signs of irritation were observable following tDCS. After two days, Participant #2 developed a non-itchy, non-lumpy lesion (diameter ca. 6mm). In this case, the lesion was located on the palmar side of the wrist, while the electrode had been placed on the dorsal side. See Fig. 1ced for images taken on days 2 and 22. The participant wished to take part in the second session, and the experimenter met with the participant for evaluation on day 48. In the safety evaluation, the participant still expressed a desire to participate in another session, and as the risk to the participant was estimated as low and no signs of skin irritation were observable, the participant was granted permission for a second session. The same stimulation protocol was applied. The participant was checked for adverse effects on days 50 and 55, i.e., days 2 and 7 following the second session. No skin reactions were observed.
Since 2013, we have used the same stimulation protocol over 400 times, and these two incidents of skin lesions have been the only observed cases. The participants had no history of such skin changes, and we thus considered these lesions to be stimulation induced. Previously, it has been suggested that the conditions of the skineelectrode impedance (effective contact size and impedance) are crucial in the formation of skin lesions [2] . While the safety features of the stimulator prevent the stimulation from continuing if the impedance rises too high, a decreased contact area and/or an insufficiently moistened electrode cannot be ruled out as causes for the first participant's lesions.
However, while the second participant's lesion resembled the other reported tDCS-induced lesions [3, 4] in timing and appearance, it did not form under the electrode. Although the lesion location was very unusual, we consider this lesion to have been caused by saline possibly having leaked out of the sponge, forming a conductive path through the bandage to the palmar aspect of the wrist. Another possibility for these lesions is a pre-existing skin defect not apparent on pre-stimulation examination. A small wound would provide a lowresistance path through the skin, which would concentrate the current in small area and could lead to injury [5] .
Both delayed [6] and non-recurring [7] skin lesions have been documented in association with tDCS. Issues such as using tap water instead of saline, insufficiently moistened electrodes, electrode shape, non-uniform pressure and individual skin properties have been suggested as potential causes for these lesions, although the causes for delayed reactions remain open. Nevertheless, we are not aware of other reports of lesions on the opposite side of the limb to the electrode location. To conclude, these lesions, at least when adhering to safety guidelines, appear rare and manageable. Nonetheless, participants should be informed of the possibility of their occurrence. In addition, care should be taken when administering saline to the sponge electrodes. These two cases are may have followed the use of an improper amount of saline; the first participant may have received an insufficient amount, while the second participant's electrode may have been excessively moistened. Similarly, the condition of the electrodes should be monitored, as in our experience, the absorbance characteristics of the electrodes change with time, and harmful substances may accumulate [6] . To account for the possibility of pre-existing skin defects, the skin should be examined before stimulation using adequate care and lighting.
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